364 filings
Page 4 of 19
6-K
msk4 rqi65
4 May 21
BioLineRx Announces Positive Top-Line Results from
7:12am
6-K
vdvy tqc8t6fw62tehri
15 Apr 21
BioLineRx Announces Presentation at 2021 American
4:01pm
6-K
ttly1y7 cy
5 Apr 21
Current report (foreign)
4:30pm
6-K
vas51llho4wwz0ym
26 Feb 21
Extraordinary General Meeting of Shareholders on
4:30pm
6-K
z1nvg01wvcfkoldc
23 Feb 21
BioLineRx Reports Year-End 2020 Financial Results
7:02am
6-K
6r44ujqc6qtw zch80qc
22 Jan 21
BioLineRx Announces Closing of $34.5 Million Bought Deal Offering and Full Exercise of
4:21pm
6-K
zl43 53ydojyva8edo
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
d20g t5f2qd1mb
16 Dec 20
Current report (foreign)
8:00am
6-K
yl1om6gp7kj1
16 Dec 20
BioLineRx Announces Final Results from Phase 2a
6:02am
6-K
2nwvqsnd 043pr
23 Nov 20
BioLineRx Reports Third Quarter 2020 Financial Results
7:08am
6-K
a8k 4ji37cg
18 Nov 20
BioLineRx Announces Initiation of Phase 1b Clinical Trial
7:09am
6-K
l9dt4rp1og cn1t5ywy
30 Oct 20
BioLineRx Announces Positive Results from Interim Analysis of
7:09am
6-K
b5zi y2jx
29 Oct 20
BioLineRx Announces Initiation of Phase 2 Clinical Trial
8:45am
6-K
0nfyijfa6
25 Sep 20
Current report (foreign)
4:33pm
6-K
vwp675 3tyq0
24 Sep 20
Current report (foreign)
4:30pm
6-K
e0y43qouwij2
19 Aug 20
2020 Annual General Meeting of Shareholders
4:34pm
6-K
g6lq6nlkun670uxgf
19 Aug 20
BioLineRx Achieves Enrollment Target in Phase 3
7:08am
6-K
7r2vmy3aloske7eiy
6 Aug 20
BioLineRx Reports Second Quarter 2020 Financial Results
7:47am
6-K
9hibh1eb1 n5h
3 Jun 20
Current report (foreign)
8:30am
6-K
gvwuudw15 fvo
1 Jun 20
BioLineRx Announces $4.39 Million Registered Direct Offering
8:05am